MODIFICATION TO CHAD THERAPEUTICS OXYMATIC MODEL 401

Conserver, Oxygen

CHAD THERAPEUTICS, INC.

The following data is part of a premarket notification filed by Chad Therapeutics, Inc. with the FDA for Modification To Chad Therapeutics Oxymatic Model 401.

Pre-market Notification Details

Device IDK003455
510k NumberK003455
Device Name:MODIFICATION TO CHAD THERAPEUTICS OXYMATIC MODEL 401
ClassificationConserver, Oxygen
Applicant CHAD THERAPEUTICS, INC. 21622 PLUMMER ST. Chatsworth,  CA  91311
ContactKevin Mcculloh
CorrespondentKevin Mcculloh
CHAD THERAPEUTICS, INC. 21622 PLUMMER ST. Chatsworth,  CA  91311
Product CodeNFB  
CFR Regulation Number868.5905 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2000-11-07
Decision Date2000-12-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.